Everybody wants more energy research – so why isn’t it coming fast enough?

Matching consumer demand with R&D may seem like an obvious starting point for innovation. But it has proven a transient goal for many countries and companies.

Two of Europe’s gene therapy pioneers have reported significant progress in the last week, bringing commercial gene therapy products yet closer to reality.

2006 was a record year for patents covering financial innovations.

Industry in Europe and elsewhere will need to act in concert to apply the recommendations iof the report into the disastrous TGN 1412 drugs trial.

The US federal spending on R&D continues its skyward progression.